A recent study has objectively demonstrated that the severity of distress experienced immediately after a diagnosis of colorectal cancer correlates with a higher risk of recurrence, underscoring the significance of stress management for patients with colorectal cancer.Stress management is especially
In a recent surge of shareholder-friendly moves, Korean pharmaceutical and biotech firms are ramping up their efforts to return value to their investors as they approach their annual shareholder meetings.Among the notable actions are substantial share buybacks and plans to enhance dividend payouts,
Professors at Korea’s five most prestigious medical schools are moving to resign en masse.Following the plan of their counterparts at Seoul National University College of Medicine, professors at Yonsei University College of Medicine have decided to submit their resignations next Monday.The Yonsei Un
Celltrion Pharm has moved closer to launching Godex Max Tablets, the successor to its flagship drug, Godex Capsules.Market insiders are watching with interest to see if the company can revitalize itself through the launch of a new drug, given its somewhat disappointing sales performance last year.On
A recent survey conducted in Korea has highlighted a concerning lack of awareness among adults regarding Body Mass Index (BMI), a crucial indicator for obesity management.BMI, calculated by dividing one's weight in kilograms by the square of their height in meters, serves as an indirect measure of b
LG Chem has entered the domestic market for treating excess fat under the chin.LG Chem has announced the launch of Bellacholine (deoxycholic acid), an injectable drug designed to target submental fat. Bellacholine is intended for the treatment of moderate to severe protrusion or excess submental fat
The developers of the innovative new drug Enhertu (trastuzumab deruxtecan) have recently ended price negotiations with the National Health Insurance Service (NHIS) to receive reimbursement as early as next month.On Monday, the NHIS announced the settlement of Enhertu’s price bargaining by updating i
Samsung Life Science Fund, created jointly between Samsung Biologics, Samsung Bioepis, and Samsung C&T, and managed by Samsung Ventures, announced its investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing antibody-drug conjugate (ADC) drugs.The latest investment
The Ministry of Health and Welfare said it issued a public notice of return-to-work to 1,308 trainee physicians who walked off their jobs in a protest against the government’s plan to sharply increase medical school admissions next year. The public notice took effect as of Tuesday. The ministry said
With a history spanning more than 350 years, Merck, the world’s oldest pharmaceutical company, is steadfastly advancing toward becoming a global leader in healthcare. In the healthcare sector, Merck has built a remarkably stable portfolio, including oncology, neurology, immunology, endocrinology, an
In a move to address the ongoing concerns within the Korean medical community regarding the expansion of the medical school admission quota, President Yoon Suk Yeol met with healthcare professionals on Monday, urging them to consider future generations and engage in dialogue without insisting on mai
In the past month, after interns and residents walked out of hospitals in protest against the government's plan to increase the medical school enrollment quota by 2,000, more than 500 cases of patient damages have been officially reported to a government support center.Delayed surgeries accounted fo
Medical school professors said both the government and the medical community should make concessions to resolve the current situation. Still, the government has stuck to its stance of increasing the medical school enrollment quota by 2,000 per year.Bang Jae-seung, head of the National Medical School
D&D Pharmatech, a Korean biotech company, said it expanded its collaboration with the U.S.-based Metsera for new treatments. This expansion includes amendments to a previously established agreement for an oral obesity treatment and the initiation of a new global technology transfer agreement for an
AITRICS, a healthcare artificial intelligence (AI) company, has unveiled AITRICS-VC (VitalCare), an AI solution for predicting patient deterioration, at major medical device exhibitions in Korea and the United States.AITRICS said Monday that it participated in the HIMSS 2024 Global Health Exhibition
Boston Scientific said Monday that it would expand technical support for the Lumenis Pulse 120H Holmium Laser System based on the MOSES technology and further strengthen its leadership in stone treatment in Korea.According to Boston Scientific, the company has recently enhanced the expertise of its
Lunit said it signed contracts to supply its AI solutions to France's largest teleradiology network, TeleDiag, and the Central Center of the Portuguese Cancer League (Liga Portuguesa Contra o Cancro, LPCC), a prominent nonprofit organization in Portugal.Lunit has recently secured a contract with Tel
CHA Biotech said Monday that it has signed a contract development and manufacturing organization (CDMO) agreement with Cell in Cells, a regenerative medicine cell therapies developer, to provide organoid treatment for cartilage diseases.Under the agreement, CHA Biotech will establish a cell bank of
The Korea Research Institute of Bioscience & Biotechnology (KRIBB) said Monday that a joint research team has developed a platform that can quickly detect multiple respiratory viruses in the field.The state-run institute said it will likely be used as a basis for developing diagnostic devices in the
Following last year's initiation, the Ministry of Food and Drug Safety (MFDS) is set to implement the Big Tech Regulatory Innovation Program this year. This year's program will see the participation of four new companies: Samsung Electronics, Samsung Fire and Marine Insurance, Hyundai Motor, and SKT